1)Kim JY, Ahn S, Kim KM, et al. Gastric inverted polyps-distinctive subepithelial lesions of the stomach:clinicopathologic analysis of 12 cases with an emphasis on neoplastic potential. Am J Surg Pathol 45:680-689, 2021
2)Hayase S, Sakuma M, Chida S, et al. Diagnosis and treatment of gastric hamartomatous inverted polyp(GHIP)using a modified combination of laparoscopic and endoscopic approaches to neoplasia with a non-exposure technique(modified CLEAN-NET):a case report. Surg Case Rep 6:1-6, 2020
3)Odashima M, Otaka M, Nanjo H, et al. Hamartomatous inverted polyp successfully treated by endoscopic submucosal dissection. Intern Med 47:259-262, 2008
4)Yamagiwa H, Matsuzaki O, Ishihara A, et al. Heterotopic gastric glands in the submucosa of the stomach. Acta Pathol Jpn 29:347-350, 1979
5)Kim DH, Kim KM, Oh SJ, et al. Early gastric cancer arising from heterotopic gastric mucosa in the gastric submucosa. J Korean Surg Soc 80(Suppl 1):S6-S11, 2011
6)Kim HS, Hwang EJ, Jang JY, et al. Multifocal adenocarcinomas arising within a gastric inverted hyperplastic polyp. Korean J Pathol 46:387-391, 2012
7)Kono T, Imai Y, Ichihara T, et al. Adenocarcinoma arising in gastric inverted hyperplastic polyp:a case report and review of the literature. Pathol Res Pract 203:53-56, 2007
8)Yang S, Farraye FA, Mack C, et al. BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum:relationship to histology and CpG island methylation status. Am J Surg Pathol 28:1452-1459, 2004
9)Matsubara A, Ogawa R, Suzuki H, et al. Activating GNAS and KRAS mutations in gastric foveolar metaplasia, gastric heterotopia, and adenocarcinoma of the duodenum. Br J Cancer 112:1398-1404, 2015
10)Cho H, Hashimoto T, Naka T, et al. Activating KRAS and GNAS mutations in heterotopic submucosal glands of the stomach. J Gastroenterol 57:333-343, 2022
11)Yamashita M, Hirokawa M, Nakasono M, et al. Gastric inverted hyperplastic polyp. Report of four cases and relation to gastritis cystica profunda. APMIS 110:717-723, 2002
12)Kim JH, Kim K-J, Rhee Y-Y, et al. Gastric-type expression signature in serrated pathway-associated colorectal tumors. Hum Pathol 46:643-656, 2015
13)Lee SH, Lee JW, Soung YH, et al. BRAF and KRAS mutations in stomach cancer. Oncogene 22:6942-6945, 2003
14)Takahashi N, Yamada Y, Taniguchi H, et al. Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancer. BMC Res Notes 7:1-7, 2014
15)van Grieken NC, Aoyma T, Chambers PA, et al. KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West:results from a large international multicentre study. Br J Cancer 108:1495-1501, 2013
16)Lee SH, Jeong EG, Soung YH, et al. Absence of GNAS and EGFL6 mutations in common human cancers. Pathology 40:95-97, 2008
17)Matsubara A, Sekine S, Kushima R, et al. Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum. J Pathol 229:579-587, 2013
18)Tirosh A, Jin DX, De Marco L, et al. Activating genomic alterations in the Gs alpha gene(GNAS)in 274 694 tumors. Genes Chromosomes Cancer 59:503-516, 2020